Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

TOF-SIMS improved chemical mapping in cells, confirming gunshot residue, tracking anti-tumor drugs, and identifying molecules in mosquitoes and wounds.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

FGF-9 speeds up the early development of certain organs, showing potential for organ regeneration.

UVFT helps diagnose hair and scalp diseases by showing different fluorescence patterns.

Fgf9 helps create new hair follicles after injury through skin T cells.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

Testosterone and finasteride improve muscle strength and size after spinal cord injury.

Tremella fuciformis Berk helps protect hair from stress-related damage.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

The document's content could not be understood or processed.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

FUE provides minimal scarring and quick recovery in hair transplantation, and surgeons not using it may lag in technology.

Follicle Stimulating Hormone is important for fertility.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.